What is the interaction between Ocrevus (ocrelizumab) and hydroxychloroquine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Ocrevus (ocrelizumab) and hydroxychloroquine can generally be used together, but this combination requires careful medical supervision. Ocrevus is a monoclonal antibody used to treat multiple sclerosis, while hydroxychloroquine is commonly prescribed for autoimmune conditions like lupus or rheumatoid arthritis. The primary concern with this combination is the potential for increased immunosuppression, as both medications affect the immune system in different ways. Ocrevus depletes B cells, while hydroxychloroquine has immunomodulatory effects.

Key Considerations

  • Patients taking both medications should be monitored closely for infections, as the combined immunosuppressive effect may increase infection risk.
  • Blood counts should be regularly checked, and any signs of infection should be promptly reported to healthcare providers.
  • Neither medication typically requires dosage adjustments when used together, but individual factors like kidney function, liver health, and other medications may influence dosing decisions.
  • This combination might be particularly beneficial for patients who have overlapping conditions requiring both treatments, such as multiple sclerosis with coexisting autoimmune disorders.

Evidence Summary

The most recent and highest quality study on ocrelizumab is from 2022 1, which demonstrates its efficacy in reducing relapse rates and disease activity in patients with relapsing forms of multiple sclerosis (RMS) or primary progressive multiple sclerosis (PPMS). While there is no direct evidence on the interaction between ocrelizumab and hydroxychloroquine, the study suggests that ocrelizumab is generally well tolerated and can be used in combination with other medications.

Monitoring and Precautions

Given the potential for increased immunosuppression, patients taking both ocrelizumab and hydroxychloroquine should be closely monitored for signs of infection and have regular blood counts checked. Healthcare providers should also be aware of the potential for increased risk of infections and take necessary precautions to minimize this risk.

Conclusion is not allowed, so the answer ends here.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.